Aspen Notre Dame de Bondeville GlaxoSmithKline Pharmaceuticals S.A.
PolandAll drugs from this manufacturer
-
The medicine helps to prevent the formation of blood clots in the blood vessels or is used to treat clots that have already formed. It is used, among other things, to prevent venous thromboembolic disease after surgery, in immobilized persons, during hemodialysis, and in the treatment of myocardial infarction or unstable angina pectoris.
Dosage form: solution for injection
Active substance Dosage nadroparin calcium 5700 j.m./0.6 ml ATC: B01AB06
-
The medicine helps to prevent the formation of blood clots in blood vessels or is used to treat clots that have already formed. It is used, among other things, to prevent thromboembolic disease after surgery, during hemodialysis, and in the treatment of myocardial infarction or unstable angina pectoris.
Dosage form: solution for injection
Active substance Dosage nadroparin calcium 9500 j.m. ATC: B01AB06
-
The medicine is used to prevent the formation of blood clots in blood vessels or to treat clots that have already formed. It is used, among other things, to prevent venous thromboembolic disease in surgery, in immobilized patients, during hemodialysis, and in the treatment of unstable angina pectoris and myocardial infarction.
Dosage form: solution for injection
Active substance Dosage nadroparin calcium 2850 j.m./0.3 ml ATC: B01AB06
-
The medicine helps to prevent the formation of blood clots in the blood vessels or is used to treat existing clots. It is used, among other things, to prevent thromboembolic disease after surgery, in immobilized patients, during hemodialysis, and in the treatment of myocardial infarction or unstable angina pectoris.
Dosage form: solution for injection
Active substance Dosage nadroparin calcium 7600 j.m./0.8 ml ATC: B01AB06
-
The medicine helps to prevent the formation of blood clots in the blood vessels or is used to treat clots that have already formed. It is used, among other things, to prevent venous thromboembolism (e.g., after surgery or in immobilized patients), to treat deep vein thrombosis, and to treat unstable angina pectoris and myocardial infarction (in combination with acetylsalicylic acid).
Dosage form: solution for injection
Active substance Dosage nadroparin calcium 3800 j.m./0.4 ml ATC: B01AB06
-
It is an anticoagulant medication used in the treatment of venous thromboembolic disease.
Dosage form: solution for injection
Active substance Dosage nadroparin calcium 11 400 IU AXa/0.6 ml ATC: B01AB06
-
The medicinal product is used in the treatment of venous thromboembolic disease (deep vein thrombosis) and has an anticoagulant effect.
Dosage form: solution for injection
Active substance Dosage nadroparin calcium 15 200 IU AXa/0.8 ml ATC: B01AB06
-
The medicinal product is used in the treatment of venous thromboembolic disease (deep vein thrombosis).
Dosage form: solution for injection
Active substance Dosage nadroparin calcium 19 000 IU AXa/1 ml ATC: B01AB06